The Dr. Charles A. Coltman, Jr., Fellowship Program awards $100,000 over two years to engage outstanding early and mid-career investigators from SWOG member institutions in advancing clinical trial methodology in an academic and cooperative group environment.
Two early career Coltman Fellows have been named for 2017:
- Mina Sedrak MD, MS, of City of Hope, has been funded to support his research project, Mixed Methods Assessment of Social Media Use among SWOG Researchers.
- Timur Mitin, MD, PhD, of Oregon Health & Science University will pursue his project, A Phase II Randomized Study of Pembrolizumab with Hypofractionated (60 Gy in 15 fractions) vs Conventional Fractionated (60 Gy in 30 fractions) Thoracic Radiotherapy in Patients with Inoperable Stage II/III Non-Small Cell Lung Cancer (NSCLC).
One mid-career Coltman Fellow was chosen for 2017:
- Paul Barr, MD, of the University of Rochester, has been funded to support his project, S1608: Characterization and Management of High-Risk Follicular Lymphoma.
SWOG institutions may nominate up to two candidates annually. This program funds investigators in various stages of research careers at current SWOG-affiliated institutions. The early career fellowship focuses on mentorship and protected time, while the mid-career fellowship aims to contribute to and enhance a research career currently underway.